Label Image (Lbl500906210)
Valsartan And Hydrochlorothiazide Tablet
Product Images NDC 50090-6210
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50090-6210). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-1 (Valsartan Hctz Figure 1)
This appears to be a chart showing the effect of various blood pressure medications on baseline systolic blood pressure. The medications listed are Velsartan HCT, Asaan Vasaan, Hydrochlorothiazide, and placebo. The goal is to have a systolic blood pressure (SBP) below 140 mmHg. The chart also shows SBP readings at various levels between 140-180 mmHg.*
Figure-2 (Valsartan Hctz Figure 2)
This is a partially visible control group data sheet for a clinical trial testing the effect of a medication on blood pressure. The medication being tested is likely a combination of Valsartan and Hydrochlorothiazide, with different dosage strengths listed. The focus is on determining the effectiveness of the drug in reducing blood pressure, specifically DBP (diastolic blood pressure), which is measured in mmHg. The baseline DBP reading is 105 mmHg, with the goal of reducing it below 90 mmHg.*
Figure-3 (Valsartan Hctz Figure 3)
This appears to be a table displaying different medications and dosages, along with a baseline systolic blood pressure measurement in millimeters of mercury (mmHg). The medications listed are "Valsaran HCT 320/25 mg", "AnA Valsartan 320 mg", "Hydrochlorothiazide 25 mg", and "Placebo". It is not clear what the other numbers represent.*
Figure-4 (Valsartan Hctz Figure 4)
This is a table showing the baseline diastolic blood pressure (DBP) in millimeters of mercury (mmHg) for different treatments. The treatments include Valsartan HCT with a dosage of 320/125 mg, Valsartan with a dosage of 320 mg, Hydrochlorothiazide with a dosage of 25 mg, and Placsbo (placebo). The DBP for the Valsartan HCT treatment is not available, but the DBP values for the other treatments are between 95 and 105 mmHg.*
Hctz-stru (Valsartan Hctz Hydrochlorothiazide)
Valsartan-str (Valsartan Hctz Valsartan)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
